The Patent Finder

Tigenix, S.A.U.

1 patent currently held · Updated Nov 22, 2026
8 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
May 2035
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

No maintenance fee falls due on this company's record before Nov 22, 2027.

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.

Showing 1 to 1 of 1

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 10,660,920Lymphocyte biomarkers for determining the clinical response to cell therapy
In force
 · USPTO record
In forceUSPTO record
Also on record, not counted in the 1: 8 patents in force now held by others · 1 lapsed for an unpaid fee · 7 ended at full term. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

11 abandoned · 4 no status recorded

Showing 1 to 10 of 15, newest filing first. An application has no patent term. A term is computed when and if it grants, and appears on that patent's own page. Where no title is shown, the bulk publication record carries none and this site holds no USPTO file history for that application.

ApplicationTitleFiledStatus
17/497,779Uses of Mesenchymal Stem CellsOct 8, 2021Abandoned
16/994,379Aug 14, 2020No status recorded
17/434,327Improved Stem Cell Populations for Allogeneic TherapyFeb 26, 2020Abandoned
17/430,623Cryopreservation of Stem CellsFeb 11, 2020Abandoned
16/722,872Use of Adipose Tissue-Derived Stromal Stem Cells in Treating FistulaDec 20, 2019Abandoned
15/581,801Cell Populations Having Immunoregulatory Activity, Method for Isolation and UsesApr 28, 2017Abandoned
15/581,777Cell Populations Having Immunoregulatory Activity, Method for Isolation and UsesApr 28, 2017Abandoned
15/464,138Mar 20, 2017No status recorded
15/341,742Mesenchymal Stem Cell-Derived Exosomes and Their UsesNov 2, 2016Abandoned
14/929,578Mesenchymal Stem Cell-Derived Exosomes and Their UsesNov 2, 2015Abandoned
10 of 15 applications shown.
Pro members see all 15 published applications.
Pro members: see all 15 applications
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited